Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRK | NVO | ABBV | ||
| Company | Merck & Company | Novo Nordisk A/S ADR | Abbvie Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 103.22 | 135.75 | 145.92 | ||
| High | 103.79 | 137.43 | 146.80 | ||
| Low | 102.48 | 135.26 | 144.70 | ||
| Last | 102.94 | 136.79 | 145.20 | ||
| Change | -0.52 | +4.45 | +0.36 | ||
| % Change | -0.50% | +3.36% | +0.25% | ||
| Volume | 11,210,801 | 1,779,500 | 6,552,900 | ||
| 20-Day Average Volume | 9,197,505 | 1,673,380 | 6,251,410 | ||
| Previous Close | 103.46 | 132.34 | 144.84 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.82 | 137.71 | 150.95 | ||
| 20-Day Raw Stochastic | 34.40% | 45.57% | 7.13% | ||
| 20-Day Relative Strength | 37.43% | 54.91% | 34.76% | ||
| Weighted Alpha | +28.30 | +41.50 | -0.20 | ||
| Today's Opinion | 40% Buy | 80% Buy | 24% Sell | ||
| Previous Opinion | 40% Buy | 80% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.32% since 01/27/23 | -0.94% since 01/27/23 | -0.74% since 01/27/23 | ||
| Low | 101.75 on 02/02/23 | 131.17 on 02/02/23 | 143.44 on 02/02/23 | ||
| High | 107.44 on 01/31/23 | 140.77 on 01/30/23 | 147.85 on 01/31/23 | ||
| 1-Month | |||||
| %Chg | -7.38% since 01/03/23 | -0.12% since 01/03/23 | -10.58% since 01/03/23 | ||
| Low | 96.36 on 01/24/23 | 130.10 on 01/12/23 | 143.44 on 02/02/23 | ||
| High | 115.49 on 01/06/23 | 144.78 on 01/24/23 | 168.11 on 01/06/23 | ||
| 3-Month | |||||
| %Chg | +4.24% since 11/03/22 | +20.13% since 11/03/22 | +0.54% since 11/03/22 | ||
| Low | 96.36 on 01/24/23 | 109.70 on 11/11/22 | 143.08 on 11/04/22 | ||
| High | 115.49 on 01/06/23 | 144.78 on 01/24/23 | 168.11 on 01/06/23 | ||
| 6-Month | |||||
| %Chg | +17.48% since 08/03/22 | +36.91% since 08/03/22 | +2.83% since 08/03/22 | ||
| Low | 84.52 on 09/21/22 | 95.02 on 09/26/22 | 134.09 on 09/30/22 | ||
| High | 115.49 on 01/06/23 | 144.78 on 01/24/23 | 168.11 on 01/06/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 260,993,680 | 309,551,520 | 256,783,280 | ||
| Shares Outstanding, K | 2,535,396 | 2,262,969 | 1,768,480 | ||
| Annual Sales | 48,704,000,000 | 22,401,280,000 | 56,197,000,000 | ||
| Annual Net Income | 13,049,000,000 | 7,598,140,000 | 11,542,000,000 | ||
| Last Quarter Sales | 14,959,000,000 | 6,165,080,000 | 14,812,000,000 | ||
| Last Quarter Net Income | 3,248,000,000 | 1,949,000,000 | 3,949,000,000 | ||
| 60-Month Beta | 0.36 | 0.49 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.62 on 02/02/23 | 0.83 on 02/01/23 | 3.66 on 10/28/22 | ||
| Latest Earnings Date | 02/02/23 | 02/01/23 | 02/09/23 | ||
| Most Recent Dividend | 0.730 on 12/14/22 | 0.407 on 08/12/22 | 1.480 on 01/12/23 | ||
| Next Ex-Dividends Date | 03/14/23 | 03/24/23 | 01/12/23 | ||
| Ratios | |||||
| Price/Earnings ttm | 13.83 | 38.14 | 10.62 | ||
